TheraVida Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

TheraVida General Information

Description

Developer of therapeutic drugs designed for the treatment of hyperhidrosis and reducing or eliminating problematic side effects for patients. The company's combination drug technology has an improved tolerability profile relative to existing therapies and delivers benefits without sacrificing efficacy for addressing both primary focal and secondary generalized hyperhidrosis, enabling healthcare providers to treat urological disorders and improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1011 Hamilton Road
  • Suite 300
  • Chapel Hill, NC 27517
  • United States
+1 (984)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1011 Hamilton Road
  • Suite 300
  • Chapel Hill, NC 27517
  • United States
+1 (984)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TheraVida Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Clinical Trials - Phase 2
4. Later Stage VC 21-Feb-2023 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B) 20-May-2016 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series A2) 22-Mar-2012 $8.9M $9.9M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 25-Jun-2008 $1.01M $1.01M Completed Startup
To view TheraVida’s complete valuation and funding history, request access »

TheraVida Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view TheraVida’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TheraVida Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic drugs designed for the treatment of hyperhidrosis and reducing or eliminating problematic side
Drug Discovery
Chapel Hill, NC
2 As of 2022

Broomfield, CO
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TheraVida Competitors (8)

One of TheraVida’s 8 competitors is Cerecin, a Venture Capital-Backed company based in Broomfield, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cerecin Venture Capital-Backed Broomfield, CO
Verge Labs Venture Capital-Backed San Francisco, CA
Entrinsic Bioscience Formerly VC-backed Norwood, MA
Pfizer (Vienna) Corporation Vienna, Austria
Brainstorm Cell Therapeutics Corporation New York, NY
You’re viewing 5 of 8 competitors. Get the full list »

TheraVida Patents

TheraVida Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022326451-A1 Pharmaceutical compositions and methods for treating hyperhidrosis Pending 11-Aug-2021
CA-3228464-A1 Pharmaceutical compositions and methods for treating hyperhidrosis Pending 11-Aug-2021
EP-4384158-A1 Pharmaceutical compositions and methods for treating hyperhidrosis Pending 11-Aug-2021
EP-4384158-A4 Pharmaceutical compositions and methods for treating hyperhidrosis Pending 11-Aug-2021
US-20240350420-A1 Pharmaceutical compositions and methods for treating hyperhidrosis Pending 11-Aug-2021 A61K9/5078
To view TheraVida’s complete patent history, request access »

TheraVida Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TheraVida Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Revelation Partners Venture Capital Minority
TVI Investments PE/Buyout Minority
Healthbox Accelerator/Incubator Minority
Sanderling Ventures Venture Capital Minority
To view TheraVida’s complete investors history, request access »

TheraVida FAQs

  • When was TheraVida founded?

    TheraVida was founded in 2005.

  • Where is TheraVida headquartered?

    TheraVida is headquartered in Chapel Hill, NC.

  • What is the size of TheraVida?

    TheraVida has 2 total employees.

  • What industry is TheraVida in?

    TheraVida’s primary industry is Drug Discovery.

  • Is TheraVida a private or public company?

    TheraVida is a Private company.

  • What is TheraVida’s current revenue?

    The current revenue for TheraVida is .

  • How much funding has TheraVida raised over time?

    TheraVida has raised $12.7M.

  • Who are TheraVida’s investors?

    Revelation Partners, TVI Investments, Healthbox, and Sanderling Ventures have invested in TheraVida.

  • Who are TheraVida’s competitors?

    Cerecin, Verge Labs, Entrinsic Bioscience, Pfizer (Vienna), and Brainstorm Cell Therapeutics are some of the 8 competitors of TheraVida.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process